Imagine being told you’ll have to self-inject a medication – without instructions – that has only been FDA approved for provider-administration. Chances are, you may not use it at all, even though it means inviting dangerous symptoms.
By Brenda Young – Wonder if a storm is coming? “Ask Brenda’s lungs,” my friends suggest.
New technology is allowing physicians to provide more personalized respiratory care.
COVID-19 has made ventilator access a front-page issue. But for patients with chronic respiratory conditions, especially Medicare beneficiaries, the challenge is hardly a new one.
The Institute for Clinical and Economic Review wants to assess the cost-effectiveness of breakthrough drugs for cystic fibrosis. But their analysis overlooks key points. View the Graphic
The introduction of a new treatment is a boon for any disease state.
Mitigating the high cost of severe asthma requires, in part, access to the appropriate medications. Those include the five monoclonal antibodies indicated for the treatment of patients with moderate to severe asthma that were reviewed in this draft evidence report. These medicines are clinically effective, as the report notes. Specifically, the report cites that the […]
Many Americans felt like they knew former first lady Barbara Bush, whose death the country mourned this month. But how much do we as a nation know about the disease that killed her?